Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium Disorders (eCaSIS)
Endogenous Calcium Stable Isotope Study (eCaSIS): Evaluation of MC-ICP-MS as a Diagnostic Tool for Metabolic Bone Diseases and Disorders of Calcium Metabolism
Sponsor: GEOMAR-Helmholtz Centre for Ocean Research
This observational or N/A phase trial investigates Bone Diseases and Osteomalacia and is currently completed. GEOMAR-Helmholtz Centre for Ocean Research leads this study, which shows 12 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2022 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Nov 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Jun 2018 — Nov 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GEOMAR-Helmholtz Centre for Ocean Research
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .